This program is supported by an independent education grant from Bayer. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
Join leading stroke prevention experts, Professor Jeffrey Saver and Professor Mike Sharma, for this accredited free online teaching session on the latest advances in Factor XIa inhibition as an approach to secondary stroke prevention. This online session is designed for physicians and healthcare professionals involved in stroke care and management, offering a comprehensive overview of the emerging research, clinical implications, and patient-centered data regarding Factor XIa inhibitors. The session includes a Q&A with the expert panel.
Accreditation: 1.5 AMA PRA Category 1 Credits™
Session Highlights:
- Differentiate Factor XIa inhibition from traditional antithrombotic mechanisms and understand its unique role in reducing bleeding risk.
- Assess the biological function of Factor XIa and explore how its inhibition may offer therapeutic options, particularly for patients with high bleeding risks.
- Identify patients who may be appropriate for this novel therapy, focusing on those who are suboptimally managed due to concerns about bleeding complications.
- Interpret and apply findings from the PACIFIC-STROKE data, focusing on the efficacy and safety profile of Factor XIa inhibitors in preventing stroke.
Presented by:
Professor Jeffrey Saver
Dr. Jeffrey Saver is a renowned neurologist at UCLA, where he serves as Medical Director of the UCLA Stroke Unit and Co-Director of the UCLA Stroke Center. He is also an Associate Professor of Neurology at UCLA's School of Medicine. Dr. Saver has authored over 80 original articles and contributed to numerous books. His research focuses on stroke prevention, acute treatment, and diagnosis. A Harvard graduate, he completed specialized training in neurology and stroke at prestigious institutions, including Brown University and the University of Iowa.
Professor Mike Sharma
Dr. Mike Sharma, MD, MSc, FRCPC, is the Director of the Stroke Program at McMaster University and Hamilton Health Sciences, where he holds the Michael G. DeGroote Chair in Stroke Prevention. His research focuses on advancing antithrombotic treatments, using MRI in stroke prevention trials, and studying the impact of anticoagulants on stroke recurrence. He has led key trials like AXIOMATIC-SSP and leads OCEANIC-STROKE. A former Chair of the Canadian Stroke Consortium, Dr. Sharma is dedicated to improving stroke care systems and shaping future clinical trials.
Who is this course for
This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:
✅ Neurologists
✅ Critical care physicians
✅ Primary Care Physicians
✅ Nurses & Nurse Practitioners
✅ Pharmacists
✅ Other Health Professionals
Continuing Education Information
This continuing education activity is provided by AffinityCE and MedAll. This activity provides continuing education credit for physicians. A statement of participation is available to other attendees.
Faculty
Professor Jeffrey Saver
Professor Mike Sharma
Disclosures
Mike Sharma Consultant for Astra Zeneca, Janssen, Anthos & Bayer. Advisory board for HLS Therapeutics, Vividion & Novartis. Research support from Javelin Medical, BMS, Astra Zeneca, Bayer & Alexion.
Intends to discuss non-FDA uses of drug products and/or devices and their unlabeled indications. This discussion relates to Factor XIa Inhibition in relation to stroke and will be disclosed to the audience when this discussion takes place.
Jeffrey Saver Clinical trial steering committee member for Bayer.
Intends to discuss non-FDA uses of drug products and/or devices and their unlabeled indications. This discussion relates to Factor XIa Inhibition in relation to stroke and will be disclosed to the audience when this discussion takes place.
Muzna Ahmed No relevant financial relationships with ineligible companies to disclose. No unapproved product related discussions to disclose.
AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.
Mitigation of Relevant Financial Relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.
Activity Accreditation for Health Professions
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Continuing Nursing Education is provided for this program through the joint providership between MedAll and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This live activity provides a maximum of 1.5 hours of continuing nursing education credit.
Criteria for Claiming CNE Credit: Participants must have registered and attended the entire program. Attendance is monitored online for participation in the entire activity.
Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this program.
CME Inquiries
For all CME policy-related inquiries, please contact us at ce@affinityced.com.